POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.13.2021, 3:01pm CEST, WHO):   U.S. 12,354    India 80,834    Brazil 85,149    France 3,604    Turkey 6,076    Russia 14,723    The United Kingdom 7,550    Italy 1,722    Argentina 26,934    Germany 1,489    Columbia 29,570    Iran 7,444    Mexico 3,282    Peru 2,799    Indonesia 7,465    South Africa 9,319    The Netherlands 1,265    Chile 7,573    Canada 1,442    Philippines 8,027    Iraq 3,831    Pakistan 1,194    Bangladesh 1,637    Japan 1,982    Malaysia 5,793    Nepal 2,382    United Arab Emirates 2,123    Saudi Arabia 1,077    Bolivia 3,244    Paraguay 2,698    Tunisia 2,228    Costa Rica 1,852    Uruguay 3,457    Kuwait 1,437    Dominican Republic 1,149    Honduras 1,400    Sri Lanka 2,354    Thailand 2,804    Cuba 1,372    Zambia 2,358    Afghanistan 1,121    Mongolia 1,792    Namibia 1,399    Uganda 1,735    China 288    Singapore 18    New Zealand 6    Australia 8    South Korea 452   

First UK patient receives coronavirus trial drug

Christian Fernsby |
The first UK patient has been treated with an experimental drug for severe lung disease related to coronavirus, the Manchester University NHS Foundation Trust said Monday.

Article continues below




The patient is part of the Oscar study conducted by GlaxoSmithKline, set up to investigate whether one of its pipeline drugs, Otilimab, can help reduce the effects of the so-called cytokine storm a severe immune reaction where the body starts to attack its own cells which was found to occur in some hospitalized coronavirus patients.

The drug is a monoclonal antibody that was already in late-stage clinical trials and was originally considered as a potential new treatment for rheumatoid arthritis.

The patient is being treated at the Manchester Royal Infirmary, part of the Manchester University NHS Foundation Trust, and was recruited to the study on Sept. 11.